Company:  PHARMAGREEN BIOTECH INC. (PHBI)
Form Type:  10-Q
Filing Date:  2/18/2020 
CIK:  0001435181 
Address:  2987 BLACKBEAR COURT 
City, State, Zip:  COQUITLAM,  V3E3A2 
Telephone:  702-803-9404 
Fiscal Year:  09/30 
Last Trade
Last Trade: 
$0.08  
Change: 
0.004 (5.00%)  
Trade Time: 
03:41 PM EST  
Market Cap: 
$8.05M
Trade PHBI now with

© 2020  
Description of Business
Pharmagreen Biotech Inc. (the "Company") was incorporated under the laws of the State of Nevada on November 26, 2007. The Company is headquartered in Coquitlam, British Columbia. The Company's mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of high CBD hemp and other flora and offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various cannabis and horticulture plants; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American high CBD hemp, Cannabis and agriculture sectors. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital.
Register and access this filing in:     
  FORM 10-Q
    PART I-FINANCIAL INFORMATION
      Item 1. Financial Statements.
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to the Condensed Consolidated Financial Statements
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures.
    PART II-OTHER INFORMATION
      Item 1. Legal Proceedings.
      Item 1A. Risk Factors.
      Item 2. Unregistered Sales of Securities and Use of Proceeds.
      Item 3. Defaults Upon Senior Securities.
      Item 4. Mine Safety Disclosure.
      Item 5. Other Information.
      Item 6. Exhibits.
    SIGNATURES*
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. 1350 AS ADOPTED